As Illumina Cuts Price of Personal Sequencing Service, CEO Says Market Growth Hinges on Analysis
June 08, 2010
As Illumina Cuts Price of Personal Sequencing Service, CEO Says Market Growth Hinges on Analysis
"It's easier and easier to create the datasets — it's increasingly difficult to extract valuable information and figure out how to apply that to an individual," said Illumina CEO Jay Flatley.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina Sees Clinical Applications for MiSeq; Plans FDA Submission in 2012
August 3, 2011 / Clinical Sequencing News - Illumina Starts Shipping 600 Gb HiSeq Reagent Kits; Takes First Orders for MiSeq
May 3, 2011 / In Sequence - Illumina Sequencing Revenue Grows 70 Percent in Q4, Driven by HiSeq
February 15, 2011 / In Sequence - HiSeq Sales Boost Illumina's Q3 Revenues, but Order Backlog Will Take Several Quarters to Fill
November 2, 2010 / In Sequence - Stronger-than-Expected Demand for HiSeq Contributes to 50 Percent Boost in Sequencing Sales for Illumina in Q2
August 3, 2010 / In Sequence